New Drug For The Body’s Powerplant Improves Mitochondrial Function

Millions of people worldwide live with mitochondrial diseases. These are inherited conditions that make it hard for the ...

Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease

Tisento Therapeutics today announced that the findings from the company’s interview study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) were published on ...
MedPage Today on MSN

Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug

The FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare ...
BioSpace

UCB Wins First FDA Approval for Ultra-Rare Mitochondrial Disease

Kygevvi is indicated for patients with thymidine kinase 2 deficiency whose symptoms arise by 12 years of age. The disease ...
EurekAlert!

Most patients with mitochondrial disease can be diagnosed via genomic sequencing

More than half of people with mitochondrial disease can be diagnosed via genomic sequencing, a finding that will revolutionise care for families, according to a new study. And the Melbourne ...
Labroots

Multiple Sclerosis May be Related to Mitochondrial Dysfunction

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the world. This disorder is characterized by the loss of a protective neuronal ...